O95819 (M4K4_HUMAN) Reviewed, UniProtKB/Swiss-Prot
Last modified
May 1, 2013.
Version 130.
History...
Names·Attributes·General annotation·Ontologies·Alt products·Sequence annotation·Sequences·References·Cross-refs·Entry info·DocumentsCustomize order
Names·Attributes·General annotation·Ontologies·Alt products·Sequence annotation·Sequences·References·Cross-refs·Entry info·DocumentsCustomize orderNames and origin
| Protein names | Recommended name: Mitogen-activated protein kinase kinase kinase kinase 4 EC=2.7.11.1 Alternative name(s): HPK/GCK-like kinase HGK MAPK/ERK kinase kinase kinase 4 Short name=MEK kinase kinase 4 Short name=MEKKK 4 Nck-interacting kinase | ||||
| Gene names |
| ||||
| Organism | Homo sapiens (Human) [Reference proteome] | ||||
| Taxonomic identifier | 9606 [NCBI] | ||||
| Taxonomic lineage | Eukaryota › Metazoa › Chordata › Craniata › Vertebrata › Euteleostomi › Mammalia › Eutheria › Euarchontoglires › Primates › Haplorrhini › Catarrhini › Hominidae › Homo![]() |
Protein attributes
| Sequence length | 1239 AA. |
| Sequence status | Complete. |
| Sequence processing | The displayed sequence is further processed into a mature form. |
| Protein existence | Evidence at protein level |
General annotation (Comments)
| Function | Serine/threonine kinase that may play a role in the response to environmental stress and cytokines such as TNF-alpha. Appears to act upstream of the JUN N-terminal pathway. Phosphorylates SMAD1 on Thr-322. Ref.1 Ref.15 |
| Catalytic activity | ATP + a protein = ADP + a phosphoprotein. Ref.1 |
| Cofactor | Magnesium. Ref.1 |
| Subunit structure | Interacts with the SH3 domain of the adapter proteins Nck By similarity. Interacts (via its CNH regulatory domain) with ATL1 (via the N-terminal region). Interacts with RAP2A (GTP-bound form preferentially). Ref.6 Ref.7 UniProtKB P97820 |
| Subcellular location | |
| Tissue specificity | Appears to be ubiquitous. Expressed in all tissue types examined. Isoform 5 appears to be more abundant in the brain. Isoform 4 is predominant in the liver, skeletal muscle and placenta. Ref.1 |
| Sequence similarities | Belongs to the protein kinase superfamily. STE Ser/Thr protein kinase family. STE20 subfamily. Contains 1 CNH domain. Contains 1 protein kinase domain. |
Ontologies
| Keywords | |
|---|---|
| Cellular component | Cytoplasm |
| Coding sequence diversity | Alternative splicing Polymorphism |
| Ligand | ATP-binding Nucleotide-binding |
| Molecular function | Kinase Serine/threonine-protein kinase Transferase |
| PTM | Acetylation Phosphoprotein |
| Technical term | Complete proteome Reference proteome |
| Gene Ontology (GO) | |
| Biological_process | intracellular protein kinase cascade Inferred from direct assay Ref.1. Source: UniProtKB regulation of JNK cascadeInferred from direct assay Ref.7. Source: UniProtKB response to stressInferred from direct assay Ref.1. Source: UniProtKB |
| Cellular_component | cytoplasm Inferred from direct assay Ref.7. Source: UniProtKB |
| Molecular_function | ATP binding Inferred from direct assay Ref.1. Source: UniProtKB protein serine/threonine kinase activityInferred from direct assay Ref.1. Source: UniProtKB small GTPase regulator activityInferred from electronic annotation. Source: InterPro |
| Complete GO annotation... | |
Alternative products
| This entry describes 5 isoforms produced by alternative splicing. [Align] [Select] | ||||||
| Isoform 1 Ref.1 (identifier: O95819-1) Also known as: Tumor-associated; This isoform has been chosen as the 'canonical' sequence. All positional information in this entry refers to it. This is also the sequence that appears in the downloadable versions of the entry. | ||||||
| Isoform 2 Ref.1 (identifier: O95819-2) The sequence of this isoform differs from the canonical sequence as follows: 495-525: Missing. 740-740: A → AGEV | ||||||
| Isoform 3 Ref.1 (identifier: O95819-3) The sequence of this isoform differs from the canonical sequence as follows: 623-623: V → VQWSHLASLK...SDSDEVPPRV 740-740: A → AGEV | ||||||
| Isoform 4 Ref.1 (identifier: O95819-4) Also known as: HGK-S; The sequence of this isoform differs from the canonical sequence as follows: 495-525: Missing. 569-622: Missing. 740-740: A → AGEV 1112-1112: H → HVRKNPHSM | ||||||
| Isoform 5 Ref.1 (identifier: O95819-5) Also known as: HGK-L; The sequence of this isoform differs from the canonical sequence as follows: 495-525: Missing. 569-622: Missing. 623-623: V → VQWSHLASLK...SDSDEVPPRV 740-740: A → AGEV 1112-1112: H → HVRKNPHSM |
Sequence annotation (Features)
| Feature key | Position(s) | Length | Description | Graphical view | Feature identifier | ||||
Molecule processing | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Initiator methionine | 1 | 1 | Removed Ref.11 | ||||||
| Chain | 2 – 1239 | 1238 | Mitogen-activated protein kinase kinase kinase kinase 4 | PRO_0000086280 | |||||
Regions | |||||||||
| Domain | 25 – 289 | 265 | Protein kinase | ||||||
| Domain | 926 – 1213 | 288 | CNH | ||||||
| Nucleotide binding | 31 – 39 | 9 | ATP By similarity UniProtKB O00506 | ||||||
| Region | 858 – 1212 | 355 | Mediates interaction with RAP2A | ||||||
Sites | |||||||||
| Active site | 153 | 1 | Proton acceptor By similarity UniProtKB O00506 | ||||||
| Binding site | 54 | 1 | ATP By similarity UniProtKB O00506 | ||||||
Amino acid modifications | |||||||||
| Modified residue | 2 | 1 | N-acetylalanine Ref.11 | ||||||
| Modified residue | 5 | 1 | Phosphoserine Ref.11 | ||||||
| Modified residue | 629 | 1 | Phosphoserine Ref.10 Ref.16 | ||||||
| Modified residue | 631 | 1 | Phosphoserine Ref.10 Ref.16 | ||||||
| Modified residue | 639 | 1 | Phosphoserine Ref.8 Ref.9 Ref.10 Ref.11 Ref.16 | ||||||
| Modified residue | 644 | 1 | Phosphoserine Ref.9 Ref.11 | ||||||
| Modified residue | 712 | 1 | Phosphoserine Ref.9 | ||||||
| Modified residue | 800 | 1 | Phosphoserine Ref.12 | ||||||
| Modified residue | 801 | 1 | Phosphoserine By similarity | ||||||
| Modified residue | 805 | 1 | Phosphoserine Ref.9 Ref.10 Ref.11 Ref.12 Ref.13 | ||||||
| Modified residue | 900 | 1 | Phosphoserine Ref.11 | ||||||
Natural variations | |||||||||
| Alternative sequence | 495 – 525 | 31 | Missing in isoform 2, isoform 4 and isoform 5. Ref.1 | VSP_007054 | |||||
| Alternative sequence | 569 – 622 | 54 | Missing in isoform 4 and isoform 5. Ref.1 | VSP_007055 | |||||
| Alternative sequence | 623 | 1 | V → VQWSHLASLKNNVSPVSRSH SFSDPSPKFAHHHLRSQDPC PPSRSEVLSQSSDSKSEAPD PTQKAWSRSDSDEVPPRV in isoform 3 and isoform 5. Ref.1 | VSP_007056 | |||||
| Alternative sequence | 740 | 1 | A → AGEV in isoform 2, isoform 3, isoform 4 and isoform 5. Ref.1 | VSP_007057 | |||||
| Alternative sequence | 1112 | 1 | H → HVRKNPHSM in isoform 4 and isoform 5. Ref.1 | VSP_007058 | |||||
| Natural variant | 712 | 1 | S → T. Ref.17 | VAR_040746 | |||||
| Isoform 3: | |||||||||
| Natural variant | 682 | 1 | D → V. | ||||||
Experimental info | |||||||||
| Sequence conflict | 658 | 1 | S → SS Ref.3 | ||||||
| Sequence conflict | 658 | 1 | S → SS Ref.4 | ||||||
| Sequence conflict | 839 | 1 | Q → R in AAO32626. Ref.2 | ||||||
Sequences
| ||||||||||||||||||||||||||||||||||||||||||
References
| « Hide 'large scale' references | |
| [1] | "A novel human STE20-related protein kinase, HGK, that specifically activates the c-Jun N-terminal kinase signaling pathway." Yao Z., Zhou G., Wang X.S., Brown A., Diener K., Gan H., Tan T.-H. J. Biol. Chem. 274:2118-2125(1999) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 4 AND 5), FUNCTION, TISSUE SPECIFICITY. Tissue: Macrophage. |
| [2] | "The STE20 kinase HGK is broadly expressed in human tumor cells and can modulate cellular transformation, invasion, and adhesion." Wright J.H., Wang X., Manning G., LaMere B.J., Le P., Zhu S., Khatry D., Flanagan P.M., Buckley S.D., Whyte D.B., Howlett A.R., Bischoff J.R., Lipson K.E., Jallal B. Mol. Cell. Biol. 23:2068-2082(2003) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1). Tissue: Glioblastoma. |
| [3] | "Prediction of the coding sequences of unidentified human genes. X. The complete sequences of 100 new cDNA clones from brain which can code for large proteins in vitro." Ishikawa K., Nagase T., Suyama M., Miyajima N., Tanaka A., Kotani H., Nomura N., Ohara O. DNA Res. 5:169-176(1998) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 38-1239 (ISOFORM 2). Tissue: Brain. |
| [4] | "The full-ORF clone resource of the German cDNA consortium." Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U., Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H., Heubner D., Hoerlein A., Michel G., Wedler H., Koehrer K., Ottenwaelder B., Poustka A., Wiemann S., Schupp I. BMC Genomics 8:399-399(2007) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 262-1239 (ISOFORM 3). Tissue: Testis. |
| [5] | "Isolation, expression profile and chromosome assignment of a novel serine/threonine kinase gene." Saito T., Seki N., Hori T. Submitted (APR-1998) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [MRNA] OF 700-1239. Tissue: Brain. |
| [6] | "A novel GTP-binding protein hGBP3 interacts with NIK/HGK." Luan Z., Zhang Y., Liu A., Man Y., Cheng L., Hu G. FEBS Lett. 530:233-238(2002) [PubMed] [Europe PMC] [Abstract] Cited for: INTERACTION WITH ATL1. |
| [7] | "Mitogen-activated protein kinase kinase kinase kinase 4 as a putative effector of Rap2 to activate the c-Jun N-terminal kinase." Machida N., Umikawa M., Takei K., Sakima N., Myagmar B.E., Taira K., Uezato H., Ogawa Y., Kariya K. J. Biol. Chem. 279:15711-15714(2004) [PubMed] [Europe PMC] [Abstract] Cited for: INTERACTION WITH RAP2A, SUBCELLULAR LOCATION. |
| [8] | "Combining protein-based IMAC, peptide-based IMAC, and MudPIT for efficient phosphoproteomic analysis." Cantin G.T., Yi W., Lu B., Park S.K., Xu T., Lee J.-D., Yates J.R. III J. Proteome Res. 7:1346-1351(2008) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-639, MASS SPECTROMETRY. Tissue: Cervix carcinoma. |
| [9] | "Kinase-selective enrichment enables quantitative phosphoproteomics of the kinome across the cell cycle." Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R., Greff Z., Keri G., Stemmann O., Mann M. Mol. Cell 31:438-448(2008) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-639; SER-644; SER-712 AND SER-805, MASS SPECTROMETRY. Tissue: Cervix carcinoma. |
| [10] | "A quantitative atlas of mitotic phosphorylation." Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E., Elledge S.J., Gygi S.P. Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-629; SER-631; SER-639 AND SER-805, MASS SPECTROMETRY. Tissue: Cervix carcinoma. |
| [11] | "Large-scale proteomics analysis of the human kinome." Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G., Mann M., Daub H. Mol. Cell. Proteomics 8:1751-1764(2009) [PubMed] [Europe PMC] [Abstract] Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-5; SER-639; SER-644; SER-805 AND SER-900, MASS SPECTROMETRY, CLEAVAGE OF INITIATOR METHIONINE. |
| [12] | "Quantitative phosphoproteomic analysis of T cell receptor signaling reveals system-wide modulation of protein-protein interactions." Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K., Rodionov V., Han D.K. Sci. Signal. 2:RA46-RA46(2009) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-800 AND SER-805, MASS SPECTROMETRY. Tissue: Leukemic T-cell. |
| [13] | "Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis." Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L., Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M. Sci. Signal. 3:RA3-RA3(2010) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-805, MASS SPECTROMETRY. Tissue: Cervix carcinoma. |
| [14] | "Initial characterization of the human central proteome." Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J. BMC Syst. Biol. 5:17-17(2011) [PubMed] [Europe PMC] [Abstract] Cited for: IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. |
| [15] | "Smad inhibition by the Ste20 kinase Misshapen." Kaneko S., Chen X., Lu P., Yao X., Wright T.G., Rajurkar M., Kariya K., Mao J., Ip Y.T., Xu L. Proc. Natl. Acad. Sci. U.S.A. 108:11127-11132(2011) [PubMed] [Europe PMC] [Abstract] Cited for: FUNCTION. |
| [16] | "System-wide temporal characterization of the proteome and phosphoproteome of human embryonic stem cell differentiation." Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J., Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V., Blagoev B. Sci. Signal. 4:RS3-RS3(2011) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-629; SER-631 AND SER-639, MASS SPECTROMETRY. |
| [17] | "Patterns of somatic mutation in human cancer genomes." Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C., Bignell G., Davies H., Teague J., Butler A., Stevens C., Edkins S., O'Meara S., Vastrik I., Schmidt E.E., Avis T., Barthorpe S., Bhamra G., Buck G. Stratton M.R.Nature 446:153-158(2007) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANT [LARGE SCALE ANALYSIS] THR-712, VARIANT [LARGE SCALE ANALYSIS] VAL-682 (ISOFORM 3). |
| + | Additional computationally mapped references. |
Cross-references
Sequence databases | |
|---|---|
| EMBL GenBank DDBJ | AF096300 mRNA. Translation: AAD16137.1. AY212247 mRNA. Translation: AAO32626.1. AB014587 mRNA. Translation: BAA31662.1. AL137755 mRNA. Translation: CAB70907.2. AB013385 mRNA. Translation: BAA33714.1. |
| IPI | IPI00006752. IPI00219799. IPI00219800. IPI00219802. IPI00639883. |
| PIR | T46481. |
| RefSeq | NP_001229488.1. NM_001242559.1. NP_004825.3. NM_004834.4. NP_663720.1. NM_145687.3. |
| UniGene | Hs.741154. |
3D structure databases | |
| ProteinModelPortal | O95819. |
| ModBase | Search... |
Protein-protein interaction databases | |
| IntAct | O95819. 15 interactions. |
| STRING | 9606.ENSP00000313644. |
PTM databases | |
| PhosphoSite | O95819. |
Proteomic databases | |
| PaxDb | O95819. |
| PRIDE | O95819. |
Protocols and materials databases | |
| StructuralBiologyKnowledgebase | Search... |
Genome annotation databases | |
| Ensembl | ENST00000347699; ENSP00000314363; ENSG00000071054. |
| GeneID | 9448. |
| KEGG | hsa:9448. |
| UCSC | uc002tbc.3. human. uc002tbd.3. human. uc002tbg.3. human. uc002tbh.3. human. |
Organism-specific databases | |
| CTD | 9448. |
| GeneCards | GC02P102313. |
| HGNC | HGNC:6866. MAP4K4. |
| HPA | HPA008476. |
| MIM | 604666. gene. |
| neXtProt | NX_O95819. |
| PharmGKB | PA30612. |
| HUGE | Search... |
| GenAtlas | Search... |
Phylogenomic databases | |
| eggNOG | COG0515. |
| HOGENOM | HOG000290708. |
| HOVERGEN | HBG036506. |
| KO | K04407. |
Enzyme and pathway databases | |
| Pathway_Interaction_DB | ceramidepathway. Ceramide signaling pathway. ephbfwdpathway. EPHB forward signaling. tnfpathway. TNF receptor signaling pathway. |
Gene expression databases | |
| ArrayExpress | O95819. |
| Bgee | O95819. |
| CleanEx | HS_MAP4K4. |
| Genevestigator | O95819. |
| GermOnline | ENSG00000071054. Homo sapiens. |
Family and domain databases | |
| InterPro | IPR001180. Citron. IPR011009. Kinase-like_dom. IPR000719. Prot_kinase_cat_dom. IPR017441. Protein_kinase_ATP_BS. IPR002290. Ser/Thr_dual-sp_kinase_dom. IPR008271. Ser/Thr_kinase_AS. [Graphical view] |
| Pfam | PF00780. CNH. 1 hit. PF00069. Pkinase. 1 hit. [Graphical view] |
| SMART | SM00036. CNH. 1 hit. SM00220. S_TKc. 1 hit. [Graphical view] |
| SUPFAM | SSF56112. Kinase_like. 1 hit. |
| PROSITE | PS50219. CNH. 1 hit. PS00107. PROTEIN_KINASE_ATP. 1 hit. PS50011. PROTEIN_KINASE_DOM. 1 hit. PS00108. PROTEIN_KINASE_ST. 1 hit. [Graphical view] |
| ProtoNet | Search... |
Other | |
| BindingDB | O95819. |
| ChEMBL | CHEMBL6166. |
| ChiTaRS | MAP4K4. human. |
| GenomeRNAi | 9448. |
| NextBio | 35392. |
| SOURCE | Search... |
Entry information
| Entry name | M4K4_HUMAN | ||||||||
| Accession | Primary (citable) accession number: O95819 Secondary accession number(s): O75172, Q9NST7 | ||||||||
| Entry history |
| ||||||||
| Entry status | Reviewed (UniProtKB/Swiss-Prot) | ||||||||
| Annotation program | Chordata Protein Annotation Program | ||||||||
| Disclaimer | Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. It is not in any way intended to be used as a substitute for professional medical advice, diagnosis, treatment or care. | ||||||||
Relevant documents
| Human and mouse protein kinases Human and mouse protein kinases: classification and index |
| Human chromosome 2 Human chromosome 2: entries, gene names and cross-references to MIM |
| Human entries with polymorphisms or disease mutations List of human entries with polymorphisms or disease mutations |
| Human polymorphisms and disease mutations Index of human polymorphisms and disease mutations |
| MIM cross-references Online Mendelian Inheritance in Man (MIM) cross-references in UniProtKB/Swiss-Prot |
| SIMILARITY comments Index of protein domains and families |

Clusters with
